drugset / Trial / NCT07835581

Study of Tegoprubart Efficacy and Safety Compared With Tacrolimus in Kidney Transplantation

NCT07835581 ↗

Phase 3 Not yet recruiting 620 enrolled Eledon Pharmaceuticals
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate the efficacy and safety of tegoprubart compared with tacrolimus in adult participants undergoing first kidney transplantation.

Timeline

Start
2026-10
Primary completion
2029-03
Completion
2033-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tacrolimus Small molecule — Oral
Subject Tegoprubart Monoclonal antibody — Intravenous

Indications